ALL KEYWORDSOsteogenesis Imperfecta (brittle bone disease)Related SpecialistsShowing 3 of 5Thomas CarpenterMDAdrienne SocciMDBeatrice LupsaMDMore Related SpecialistsRelated Clinical TrialsStudy to Assess the Efficacy and Safety of Setrusumab in Participants With Osteogenesis ImperfectaOrthopaedics, Muscle & BoneGender:All GendersAge:5 years - 25 yearsSetrusumab vs bisphosphonates in children from 2 to < 7 years old with osteogenesis imperfecta (OI)Genetics
